Breaking News Instant updates and real-time market news.

DXCM

Dexcom

$58.08

0.09 (0.16%)

, ABT

Abbott

$58.93

0.005 (0.01%)

11:58
01/04/18
01/04
11:58
01/04/18
11:58

Dexcom falls after Abbott receives Medicare approval for Libre

Shares of Dexcom (DXCM) are sinking after Abbott (ABT) announced that FreeStyle Libre, its new continuous glucose monitoring system, is now available to Medicare patients. ABBOTT ANNOUNCES MEDICARE COVERAGE: This morning, Abbott announced that the FreeStyle Libre System, the company's rnew continuous glucose monitoring system, is now available to Medicare patients, having met the codes for therapeutic CGM systems used for coverage by the U.S. Centers for Medicare & Medicaid Services. Coverage includes all Medicare patients with diabetes who use insulin and who meet the eligibility criteria. Abbott said that the factory-calibrated FreeStyle Libre system is the only CGM system recognized by Medicare that requires no user calibration whatsoever and also does not require the need for routine fingersticks. BUYING OPPORTUNITY: Following Abbott's announcement, Piper Jaffray analyst JP McKim said he believes Abbott's Medicare approval for Libre is "more market-expanding than share-taking" for Dexcom, and maintained an Overweight rating on Dexcom shares, seeing the pullback as a buying opportunity for longer-term investors. The analyst believes the sooner-than-expected Medicare coverage minimizes upside potential for Medicare revenue in 2018, but added that CGM adoption is expected to accelerate and he thinks "the superior product" of Dexcom will win more Medicare patients. NORTHLAND DOWNGRADES: Northland analyst Suraj Kalia downgraded Dexcom to Underperform from Market Perform after Abbott announced Medicare coverage for the Libre FGM. The analyst believes it undercuts Dexcom's competitive advantages, and contends that there is additional headline risk vis-a-vis Medtronic's (MDT) Guardian Connect CGM approval in the pipeline. Further, Kalia believes Dexcom's stock is bound to be under pressure over the next 12-18 months. The analyst added that Dexcom does have the best in class sensor and the company has an "excellent" pipeline but argued that the Libre FGM may be "good enough" for a large chunk of patients, especially as its about one-tenth the cost of Dexcom's upfront price. OTHER ANALYST COMMENTARY: Cowen analyst Doug Schenkel believes shares of Dexcom are down too much following Abbott's announcement and that a 10% sellof "appears disproportionate" on a three month timing swing on an expected event. Baird analyst Jeff Johnson said he believes today's news may not be create as much near-term risk to Dexcom numbers as investors believe. PRICE ACTION: Dexcom dropped 10.8%, or $6.29, to $51.79 at midday.

DXCM

Dexcom

$58.08

0.09 (0.16%)

ABT

Abbott

$58.93

0.005 (0.01%)

MDT

Medtronic

$83.44

-0.48 (-0.57%)

  • 04

    Jan

  • 24

    Jan

  • 26

    Feb

DXCM Dexcom
$58.08

0.09 (0.16%)

01/04/18
01/04/18
DOWNGRADE

Underperform
Dexcom to Underperform at Northland
As previously reported, Northland analyst Suraj Kalia downgraded Dexcom (DXCM) to Underperform from Market Perform after Abbott (ABT) announced Medicare coverage for its Libre FGM. The analyst believes it undercuts Dexcom's competitive advantages, and contends that there is additional headline risk vis-a-vis Medtronic' (MDT) Guardian Connect CGM approval in the pipeline. Further, Kalia believes Dexcom's stock is bound to be under pressure over the next 12-18 months.
01/04/18
COWN
01/04/18
NO CHANGE
COWN
Dexcom sell-off overdone, says Cowen
01/04/18
COWN
01/04/18
NO CHANGE
Target $70
COWN
Outperform
Dexcom selling off too much on Abbott news, says Cowen
Cowen analyst Doug Schenkel believes shares of Dexcom (DXCM) are down too much after Abbott (ABT) announced Medicare reimbursement for Libre. Given Libre's dosing claim, this development was expected, though it came three months earlier than expected, Schenkel tells investors in a research note. He believes a 10% selloff "appears disproportionate" on a three month timing swing on an expected event. The analyst keeps an Outperform rating on Dexcom with a $70 price target. The stock in late morning trading is down 11% to $51.86.
01/04/18
BARD
01/04/18
NO CHANGE
Target $58
BARD
Neutral
Risk to Dexcom estimates may be less than feared, says Baird
Baird analyst Jeff Johnson says his channel checks indicate Abbott's (ABT) Libre will be reimbursed by Centers for Medicare & Medicaid Services using the same codes as Dexcom's (DXCM) G5, meaning at the same monthly price of $250 per patient. The analyst has long believed superior technology, or G5 over Libre, will win out at price parity. As such, he believes today's news may not be create as much near-term risk to Dexcom numbers as investors believe. The analyst, however, keeps a Neutral rating on Dexcom shares, despite today's 11% selloff. He believes longer-term CMS and commercial payer questions remain.
ABT Abbott
$58.93

0.005 (0.01%)

01/04/18
PIPR
01/04/18
NO CHANGE
PIPR
Dexcom pullback a buying opportunity for longer-term investors, says Piper
Piper Jaffray analyst JP McKim believes Abbott's (ABT) Medicare approval for Libre is "more market-expanding than share-taking" for Dexcom (DXCM), and maintained an Overweight rating on Dexcom shares, seeing the pullback as a buying opportunity for longer-term investors. Dexcom shares are down 8.75% to $53 in late morning trading.
MDT Medtronic
$83.44

-0.48 (-0.57%)

01/02/18
BOFA
01/02/18
UPGRADE
BOFA
Buy
Medtronic upgraded to Buy from Neutral at BofA/Merrill
01/02/18
BOFA
01/02/18
UPGRADE
BOFA
Buy
Medtronic upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Medtronic to Buy from Neutral and increased its price target to $94 from $90. Analyst Bob Hopkins believes Medtronic is on the "verge" of delivering more consistent growth driven by its pipeline and manufacturing footprint reduction, which should drive multiple expansion.
01/03/18
EVER
01/03/18
INITIATION
Target $92.5
EVER
Outperform
Medtronic initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Medtronic with an Outperform rating and $92.50 price target. The analyst has confidence in the company's revenue growth accelerating in the second half of 2018. He finds the stock "compelling" at current share levels.

TODAY'S FREE FLY STORIES

SANM

Sanmina

$27.70

0.1 (0.36%)

, CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

19:00
04/23/18
04/23
19:00
04/23/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

SANM

Sanmina

$27.70

0.1 (0.36%)

CDNS

Cadence Design

$36.75

-0.27 (-0.73%)

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

TRMB

Trimble

$36.13

-0.44 (-1.20%)

RUSHA

Rush Enterprises

$43.00

-0.3 (-0.69%)

SLM

Sallie Mae

$11.68

0.015 (0.13%)

ZION

Zions Bancorp

$54.27

0.47 (0.87%)

AMP

Ameriprise

$145.45

1.74 (1.21%)

GOOG

Alphabet

$1,067.70

-5.03 (-0.47%)

ZYME

Zymeworks

$12.08

0.095 (0.79%)

TNDM

TNDM

LQ

La Quinta

$19.55

0.09 (0.46%)

BP

BP

$43.92

0.415 (0.95%)

DGICA

Donegal Group

$15.07

-0.11 (-0.72%)

AMTD

TD Ameritrade

$61.21

-0.04 (-0.07%)

WHR

Whirlpool

$150.31

0.885 (0.59%)

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

BRO

Brown & Brown

$26.56

0.6 (2.31%)

ABX

Barrick Gold

$12.93

-0.23 (-1.75%)

OI

Owens-Illinois

$21.76

0.13 (0.60%)

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

BBBY

Bed Bath & Beyond

$17.35

0.22 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 23

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 24

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 26

    Apr

  • 03

    May

  • 04

    May

  • 08

    May

  • 09

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 12

    Jun

  • 26

    Apr

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:45
04/23/18
04/23
18:45
04/23/18
18:45
Periodicals
United Continental CEO to forego 2017 bonus, Bloomberg reports »

United Continental CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

UAL

United Continental

$70.32

-1.405 (-1.96%)

18:37
04/23/18
04/23
18:37
04/23/18
18:37
Hot Stocks
United Continental chairman Milton will not stand for reelection »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

INFY

Infosys

$17.43

0.05 (0.29%)

18:12
04/23/18
04/23
18:12
04/23/18
18:12
Hot Stocks
Infosys sees FY18 revenue growth trending at 7.2% rate »

Comments from the Infosys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

SFNC

Simmons First National

$28.95

0.2 (0.70%)

18:04
04/23/18
04/23
18:04
04/23/18
18:04
Earnings
Simmons First National reports Q1 core EPS 57c, consensus 52c »

Reports Q1 provision for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 14

    May

  • 24

    Sep

HLX

Helix Energy

$6.24

-0.245 (-3.78%)

18:01
04/23/18
04/23
18:01
04/23/18
18:01
Earnings
Helix Energy reports Q1 EPS (2c), consensus (6c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:50
04/23/18
04/23
17:50
04/23/18
17:50
Hot Stocks
Einhorn says Assured Guaranty has a lot of exposure to Puerto Rico »

Says Assured…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:45
04/23/18
04/23
17:45
04/23/18
17:45
Hot Stocks
Tivity Health falls 19% after Q1 revenue misses estimates »

Shares of Tivity Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

TVTY

Tivity Health

$39.50

-0.6 (-1.50%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Earnings
Tivity Health affirms FY18 EPS 2.12-$2.20, consensus $2.16 »

Backs FY18 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 12

    Jun

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:42
04/23/18
04/23
17:42
04/23/18
17:42
Hot Stocks
Greenlight Capital's Einhorn says Assured Guaranty has no room for losses »

Says Assured Guaranty …

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

HD

Home Depot

$177.73

0.68 (0.38%)

, LOW

Lowe's

$84.34

0.71 (0.85%)

17:40
04/23/18
04/23
17:40
04/23/18
17:40
Initiation
Home Depot, Lowe's, Tractor Supply, O'Reilly Automotive, AutoZone, At Home Group, National Vision initiated  »

Home improvement and…

HD

Home Depot

$177.73

0.68 (0.38%)

LOW

Lowe's

$84.34

0.71 (0.85%)

TSCO

Tractor Supply

$61.64

1.33 (2.21%)

ORLY

O'Reilly Automotive

$222.54

1.06 (0.48%)

AZO

AutoZone

$599.45

3.63 (0.61%)

HOME

At Home Group

$34.69

-0.305 (-0.87%)

EYE

National Vision

$31.57

-0.02 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    May

  • 12

    Jun

WBS

Webster Financial

$59.94

0.555 (0.93%)

17:37
04/23/18
04/23
17:37
04/23/18
17:37
Hot Stocks
Webster Financial increases dividend 7c to 33c »

Webster Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SCHW

Charles Schwab

$55.37

0.37 (0.67%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Hot Stocks
Charles Schwab chairman Charles Schwab sells 250K shares »

The chairman of brokerage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

NDAQ

Nasdaq

$86.92

-0.52 (-0.59%)

17:36
04/23/18
04/23
17:36
04/23/18
17:36
Periodicals
Nasdaq proposes to let companies pick where their shares trade, Reuters says »

Nasdaq said it plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

GLRE

Greenlight Capital Re

, AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

17:35
04/23/18
04/23
17:35
04/23/18
17:35
Hot Stocks
Greenlight Capital's Einhorn says short Assured Guaranty »

David Einhorn, president,…

GLRE

Greenlight Capital Re

AGO

Assured Guaranty

$35.90

-0.81 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 04

    May

SFE

Safeguard Scientifics

$12.25

-0.25 (-2.00%)

17:32
04/23/18
04/23
17:32
04/23/18
17:32
Hot Stocks
Safeguard Scientifics enters agreement with Sierra Capital »

Safeguard Scientifics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:31
04/23/18
04/23
17:31
04/23/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Epizyme »

Epizyme down 19% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

EROS

Eros International

$11.63

-0.05 (-0.43%)

17:26
04/23/18
04/23
17:26
04/23/18
17:26
Hot Stocks
Mangrove's August says has questions around Eros' receivables »

Says Eros is suing him.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRO

Brown & Brown

$26.56

0.6 (2.31%)

17:24
04/23/18
04/23
17:24
04/23/18
17:24
Earnings
Brown & Brown reports Q1 adjusted EPS 29c, consensus 32c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

CODA

Coda Octopus Group

$4.07

0.12 (3.04%)

17:23
04/23/18
04/23
17:23
04/23/18
17:23
Syndicate
Breaking Syndicate news story on Coda Octopus Group  »

Coda Octopus Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUI

Sun Communities

$91.54

0.25 (0.27%)

17:19
04/23/18
04/23
17:19
04/23/18
17:19
Earnings
Sun Communities reports Q1 EPS 38c, consensus 28c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

EROS

Eros International

$11.63

-0.05 (-0.43%)

17:17
04/23/18
04/23
17:17
04/23/18
17:17
Hot Stocks
Mangrove's August says short Eros International »

Nathaniel August, founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CASA

Casa Systems

$29.81

-0.35 (-1.16%)

17:16
04/23/18
04/23
17:16
04/23/18
17:16
Syndicate
Casa Systems files to sell 7.35M shares of common stock for holders »

Morgan Stanley & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 26

    Apr

EPZM

Epizyme

$15.25

-0.65 (-4.09%)

17:16
04/23/18
04/23
17:16
04/23/18
17:16
Hot Stocks
Breaking Hot Stocks news story on Epizyme 

Epizyme trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

SD

SandRidge Energy

$14.86

0.22 (1.50%)

17:15
04/23/18
04/23
17:15
04/23/18
17:15
Hot Stocks
Icahn demands right to inspect certain SandRidge records »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.